Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018;1(1):20.
doi: 10.1186/s42155-018-0026-0. Epub 2018 Sep 21.

Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide

Pavel Hoffmann  1 , Ahmed Al-Ani  1 , Thomas von Lueder  2 , Jenny Hoffmann  3 , Peter Majak  4 , Ove Hagen  5 , Helga Loose  6 , Nils Einar Kløw  7 , Anders Opdahl  1
Affiliations

Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide

Pavel Hoffmann et al. CVIR Endovasc. 2018.

Abstract

Background: Despite decreasing sheath diameter, access site bleeding and vascular complications are still a major concern in transfemoral aortic valve implantation (TAVI), and may increase morbidity and even increase mortality. The aim was to compare safety of arterial closure in transfemoral TAVI with two different principles, pre-suture with ProGlide and collagen plug closure with Manta.

Results: Seventy-six patients treated with ProGlide and 75 with Manta were analysed. The endpoints were 1: access site vascular complications and 2: non-planned vascular or endovascular surgery at the puncture site. Complications occurred in 2 (2.7%) ProGlide and in 8 (10.7%) Manta cases, p = 0.047. During the learning phase there were no significant differences. In the established phase there was one event (2%) in the ProGlide group, compared to 6 endpoints (12.0%), p = 0.047, in the Manta group.Unplanned surgery or intervention was seen in two (2.7%) ProGlide and in 7 (9.3%) Manta patients, p = ns. There were no significant differences during the learning phase. In established use, endpoints occurred more frequently in patients treated with the Manta device (12%), than in patients treated with the ProGlide (2%), p = 0.047.

Conclusion: The ProGlide presuture closure device was associated with significantly lower rates of vascular complications and lower rates of surgery and interventions compared to the collagen plug Manta system.

Trial registration: The data were collected from Internal quality control registry on treatment of patients with valvular heart disease with or without coronary artery disease, No 2014/17280, Oslo University Hospital, Ullevål.

Keywords: Access site complications; Manta; ProGlide; Transfemoral TAVI; Vascular closure device.

PubMed Disclaimer

Conflict of interest statement

The data were collected from Internal quality control registry on treatment of patients with valvular heart disease with or without coronary artery disease, No 2014/17280, Oslo University Hospital, Ullevål.Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Arsalan M, Weferling M, Hecker F, Filardo G, Kim W-K, Pollock BD, Van Linden A, Arsalan-Werner A, Renker M, Doss M, Kalbas S, Hamm CW, Liebetrau C, Mack MJ, Walther T. TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model. EuroIntervention. 2018;13:1520–1526. doi: 10.4244/EIJ-D-17-00421. - DOI - PubMed
    1. Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra SA, Mavromatis K, Leshnower BG, Guyton RA, Kanitkar M, Keegan P, Simone A, Stewart JP, Ghasemzadeh N, Block P, Thourani VH. Comparison of Transfemoral Transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach). Outcomes and cost analysis. JACC : cardiovascular. Interventions. 2014;7:898–904. - PubMed
    1. Barbash IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, Abramowitz Y, Latib A, Nguyen C, Deuschl F, Segev A, Sideris K, Buccheri S, Simonato M, Della Rosa F, Tamburino C, Jilaihawi H, Miyazaki T, Himbert D, Schofer N, Guetta V, Bleiziffer S, Tchetche D, Imme` S, raj R, Makkar RR, Vahanian A, Treede H, Lange R, Colombo A, Dvir D. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J. 2015;36:3370–3379. doi: 10.1093/eurheartj/ehv417. - DOI - PubMed
    1. Biancari F, Romppanen H, Savontaus M, Siljander A, Mäkikallio T, Piira O-P, Piuhola J, Vilkki V, Ylitalo A, Vasankari T, Airaksinen J, Niemelä M. MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation. Int J Cardiol. 2018;263:29–31. doi: 10.1016/j.ijcard.2018.04.065. - DOI - PubMed
    1. De Palma R, Settergren M, Rück A, Linder R, Saleh N. Impact of percutaneous femoral arteriotomy closure using the MANTA™ device on vascular and bleeding complications after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2018;00:1–8. doi: 10.1002/ccd.27595. - DOI - PubMed

LinkOut - more resources